Literature DB >> 18202092

Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Gül Dölen1, Mark F Bear.   

Abstract

Metabotropic glutamate receptors (mGluRs) have been implicated in a diverse variety of neuronal functions. Studies reviewed here indicate that exaggerated signalling through mGluR5 can account for multiple cognitive and syndromic features of fragile X syndrome, the most common inherited form of mental retardation and autism. Since a reduction of mGluR5 signalling can reverse fragile X phenotypes, these studies provide a compelling rationale for the use of mGluR5 antagonists for the treatment of fragile X and related disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202092      PMCID: PMC2375688          DOI: 10.1113/jphysiol.2008.150722

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  47 in total

1.  Internalization of ionotropic glutamate receptors in response to mGluR activation.

Authors:  E M Snyder; B D Philpot; K M Huber; X Dong; J R Fallon; M F Bear
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

2.  Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice.

Authors:  C Chiamulera; M P Epping-Jordan; A Zocchi; C Marcon; C Cottiny; S Tacconi; M Corsi; F Orzi; F Conquet
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

3.  Rapid ocular dominance plasticity requires cortical but not geniculate protein synthesis.

Authors:  Sharif Taha; Michael P Stryker
Journal:  Neuron       Date:  2002-04-25       Impact factor: 17.173

4.  A morphological correlate of synaptic scaling in visual cortex.

Authors:  Wes Wallace; Mark F Bear
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

5.  Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons.

Authors:  Peter W Vanderklish; Gerald M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

6.  Fragile-X syndrome: a particular epileptogenic EEG pattern.

Authors:  S A Musumeci; R M Colognola; R Ferri; G L Gigli; M A Petrella; S Sanfilippo; P Bergonzi; C A Tassinari
Journal:  Epilepsia       Date:  1988 Jan-Feb       Impact factor: 5.864

7.  Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study.

Authors:  M Marin-Padilla
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

8.  The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Authors:  Z Li; Y Zhang; L Ku; K D Wilkinson; S T Warren; Y Feng
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

9.  Macroorchidism and fragile X in mentally retarded males. Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28).

Authors:  K B Nielsen; N Tommerup; H V Dyggve; C Schou
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Expression of metabotropic glutamate receptors in the rat and human testis.

Authors:  M Storto; M Sallese; L Salvatore; R Poulet; D F Condorelli; P Dell'Albani; M F Marcello; R Romeo; P Piomboni; N Barone; F Nicoletti; F Nicoletti; A De Blasi
Journal:  J Endocrinol       Date:  2001-07       Impact factor: 4.286

View more
  130 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

3.  In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.

Authors:  Christine DeLorenzo; Matthew S Milak; Kathleen G Brennan; J S Dileep Kumar; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236

Review 4.  N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Brain Res Bull       Date:  2010-04-24       Impact factor: 4.077

5.  Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens.

Authors:  Peter H Frederikse; Anoop Nandanoor; Chinnaswamy Kasinathan
Journal:  Neurochem Res       Date:  2015-08-23       Impact factor: 3.996

6.  Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling.

Authors:  Morgan Bridi; Hannah Schoch; Cédrick Florian; Shane G Poplawski; Anamika Banerjee; Joshua D Hawk; Giulia S Porcari; Camille Lejards; Chang-Gyu Hahn; Karl-Peter Giese; Robbert Havekes; Nelson Spruston; Ted Abel
Journal:  JCI Insight       Date:  2020-03-12

Review 7.  LTD-like molecular pathways in developmental synaptic pruning.

Authors:  Claire Piochon; Masanobu Kano; Christian Hansel
Journal:  Nat Neurosci       Date:  2016-09-27       Impact factor: 24.884

8.  Agonist-dependent signaling by group I metabotropic glutamate receptors is regulated by association with lipid domains.

Authors:  Ranju Kumari; Catherine Castillo; Anna Francesconi
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

9.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

10.  Pharmacological rescue of cortical synaptic and network potentiation in a mouse model for fragile X syndrome.

Authors:  Tao Chen; Jing-Shan Lu; Qian Song; Ming-Gang Liu; Kohei Koga; Giannina Descalzi; Yun-Qing Li; Min Zhuo
Journal:  Neuropsychopharmacology       Date:  2014-02-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.